Neuronal survival following remote adenovirus gene delivery

被引:27
作者
Boulis, NM
Turner, DE
Imperiale, MJ
Feldman, EL
机构
[1] Univ Michigan, Neurobiol Sect, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Neurol, Ctr Gene Therapy, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Microbiol, Ctr Gene Therapy, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Immunol, Ctr Gene Therapy, Ann Arbor, MI 48109 USA
关键词
apoptosis; beta-galactosidase; central nervous system; gene therapy; spinal cord;
D O I
10.3171/spi.2002.96.2.0212
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. Virus-mediated central nervous system gene delivery is a promising means of treating traumatized tissue or degenerative diseases. In the present study, the authors examined gene expression and neuronal survival in the spinal cord after sciatic nerve administration of an adenovirus vector expressing a LacZ reporter gene. Method, The time course of adenovirus gene expression. DNA fragmentation, and neuronal density ere quantified in rat lumbar spinal cord by staining for beta-galactosidase (beta-Gal), terminal deoxynucleotidyl transferase, and cresyl violet after microinjection of either saline or the reporter virus into rat sciatic nerve. The expression of beta-Gal following remote hector delivery, peaked at 7 days and declined thereafter but was not accompanied by neuronal cell death. as measured by DNA fragmentation. No significant difference in spinal motor neuron density was detected between virus-treated and control rats at any time point examined. Although the,pinal cords removed from rats treated with cyclosporine prior to adenovirus injection contained substantially more neurons staining for beta-Gal at 7 days (67% of total neurons), the decay in the number of stained neurons was not paralleled by a decline in motor neuron density. Conclusions. The authors conclude that remote gene expression is suppressed by a noncytolytic process.
引用
收藏
页码:212 / 219
页数:8
相关论文
共 46 条
  • [1] Neuroprotection of spinal motoneurons following targeted transduction with an adenoviral vector carrying the gene for glial cell line-derived neurotrophic factor
    Baumgartner, BJ
    Shine, HD
    [J]. EXPERIMENTAL NEUROLOGY, 1998, 153 (01) : 102 - 112
  • [2] Adenoviral nerve growth factor and β-galactosidase transfer to spinal cord:: a behavioral and histological analysis
    Boulis, NM
    Bhatia, V
    Brindle, TI
    Holman, HT
    Krauss, DJ
    Blaivas, M
    Hoff, JT
    [J]. JOURNAL OF NEUROSURGERY, 1999, 90 (01) : 99 - 108
  • [3] Characterization of adenoviral gene expression in spinal cord after remote vector delivery
    Boulis, NM
    Turner, DE
    Dice, JA
    Bhatia, V
    Feldman, EL
    [J]. NEUROSURGERY, 1999, 45 (01) : 131 - 137
  • [4] GENE DELIVERY INTO THE BRAIN USING VIRUS VECTORS
    BREAKEFIELD, XO
    [J]. NATURE GENETICS, 1993, 3 (03) : 187 - 189
  • [5] Interactions between the immune system and gene therapy vectors: Bidirectional regulation of response and expression
    Bromberg, JS
    Debruyne, LA
    Qin, LH
    [J]. ADVANCES IN IMMUNOLOGY, VOL 69, 1998, 69 : 353 - 409
  • [6] Byrnes AP, 1996, GENE THER, V3, P644
  • [7] ADENOVIRUS GENE-TRANSFER CAUSES INFLAMMATION IN THE BRAIN
    BYRNES, AP
    RUSBY, JE
    WOOD, MJA
    CHARLTON, HM
    [J]. NEUROSCIENCE, 1995, 66 (04) : 1015 - 1024
  • [8] Direct intracerebral nerve growth factor gene transfer using a recombinant adenovirus: Effect on basal forebrain cholinergic neurons during aging
    CastelBarthe, MN
    JazatPoindessous, F
    Barneoud, P
    Vigne, E
    Revah, F
    Mallet, J
    Lamour, Y
    [J]. NEUROBIOLOGY OF DISEASE, 1996, 3 (01) : 76 - 86
  • [9] Dopaminergic neurons protected from degeneration by GDNF gene therapy
    ChoiLundberg, DL
    Lin, Q
    Chang, YN
    Chiang, YL
    Hay, CM
    Mohajeri, H
    Davidson, BL
    Bohn, MC
    [J]. SCIENCE, 1997, 275 (5301) : 838 - 841
  • [10] Toxicity of replication-defective adenoviral recombinants in dissociated cultures of nervous tissue
    Durham, HD
    Lochmuller, H
    Jani, A
    Acsadi, G
    Massie, B
    Karpati, G
    [J]. EXPERIMENTAL NEUROLOGY, 1996, 140 (01) : 14 - 20